http://www.prnewswire.com/news-releases/myos-rens-technology-announces-the-date-for-the-release-of-third-quarter-2019-financial-results-conference-call-and-webcast-300948713.html

CEDAR KNOLLS, N.J., Oct. 31, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, will announce financial results for the third quarter of 2019 on Friday, November 8 at 10 AM (ET).

The Company will host a conference call on Friday, November 8, 2019 at 10 AM (ET), at which time MYOS Chief Executive Officer Joseph Mannello will provide commentary on earnings results and provide updates on its ongoing clinical studies and commercial efforts.